ѻýҕl

<ѻýҕl class="page-title">Meeting Coverage

CROI Expert Roundtable

<ѻýҕl class="page-description">Expert Roundtable from Conference on Retroviruses and Opportunistic Infections
Third 'Cured' HIV Patient Headlines CROI 2022

Our panel discusses the woman in remission after a donated umbilical cord blood transplant

image
<ѻýҕl class="section_title">Latest CROI Expert Roundtable Meeting Coverage
Second-Line Dolutegravir for HIV Favorable to Other Boosted PIs

Outcomes in VISEND improved when switching to dolutegravir plus either FTC/TAF or 3TC/TDF

March 14, 2022
Long-Acting Prevention and Treatment of HIV: CROI 2022 Part 2

Our team of experts discuss new results on lenacapavir and cabotegravir plus rilpivirine

March 7, 2022
Long-Acting Prevention and Treatment of HIV: CROI 2022 Part 1

Monica Gandhi leads a roundtable discussion with Carlos del Rio and Renee Heffron

February 28, 2022